Breaking News
Get 45% Off 0
🚨 Don’t miss your updated list of AI-picked stocks for this month
Pick Stocks with AI

Zacks Investment Research Zacks Investment Research

Zacks Investment Research's Opinion & Analysis.
Featured here: a complete archive of all posts and research produced by Zacks Investment Research, including current material.
Company News For Mar 18, 2020 By Zacks Investment Research - Mar 17, 2020

Shares of Pfizer Inc.'s (NYSE:PFE) surged 6.6% after signing a deal with BioNTech SE (NASDAQ:BNTX) for developing a potential coronavirus vaccine.Shares of Regeneron Pharmaceuticals Inc. ...

Automatic Data Processing Hits A New 52-Week Low: Here's Why By Zacks Investment Research - Mar 17, 2020

Shares of Automatic Data Processing, Inc. (NASDAQ:ADP) scaled a new 52-week low of $118.43 in the trading session on Mar 17, before closing a tad higher at $129.39.The company’s shares have...

Should You Invest In The SPDR S&P Semiconductor ETF (XSD)? By Zacks Investment Research - Mar 17, 2020

If you're interested in broad exposure to the Technology - Semiconductors segment of the equity market, look no further than the SPDR S&P Semiconductor ETF (NYSE:XSD), a passively managed exchange...

Campbell (CPB) Hits Fresh High: Is There Still Room To Run? By Zacks Investment Research - Mar 17, 2020

Shares of Campbell Soup (CPB) have been strong performers lately, with the stock up 11.7% over the past month. The stock hit a new 52-week high of $57.54 in the previous session. Campbell Soup has...

Johnson & Johnson (JNJ) Catches Eye: Stock Jumps 7.4% By Zacks Investment Research - Mar 17, 2020

Johnson & Johnson (NYSE:JNJ) was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares changing hands than...

Hess Slashes 2020 Capital Budget As Oil Price Remains Soft By Zacks Investment Research - Mar 17, 2020

Hess Corporation (NYSE:HES) announced that it has revised downward its 2020 capital budget in the wake of a weak crude pricing scenario.The company’s revised capital budget for this year is at...

Coronavirus Stock Market Sell-Off: Should You Buy Now? By Zacks Investment Research - Mar 17, 2020

(0:30) - When Should You Buy Into The Stock Market?(5:45) - How To Invest While The Stock Market Falls(11:05) - Stocks To Watch When The Recovery Comes(20:40) - Episode Roundup: UTLA, HD, JILL, BBBY,...

Market Roars Back On Trillion-Dollar Stimulus Plan By Zacks Investment Research - Mar 17, 2020

The Dow soared more than 1000 points on Tuesday and got back a little more than a third of yesterday’s 3000-point plunge. Yep, that’s where we are in this crisis. A major index jumps...

Concho Resources Endures Weak Oil Price, Trims Capex To $2B By Zacks Investment Research - Mar 17, 2020

Coronavirus, the WHO- (World Health Organization) declared pandemic currently wreaking havoc across the world, has hit the oil industry big time by compromising on China's fuel demand due to...

Abeona Treats First Patient In Pivotal Gene Therapy Study By Zacks Investment Research - Mar 17, 2020

Abeona Therapeutics Inc. (NASDAQ:ABEO) announced that it has treated the first patient in the pivotal phase III study — VIITAL — evaluating its lead pipeline candidate, EB-101, in...

Continue with Apple
Continue with Google
or
Sign up with Email